A study published in JNCCN—Journal of the National Comprehensive Cancer Network demonstrated that among all patients with neuroendocrine tumors, the risk of dying of cancer was higher than that of dying of other causes—but mortality varies by primary tumor site.
The Biden administration has left NIH in a weakened state, intensifying politicization of science on Capitol Hill and eroding the bipartisan support the government’s premier biomedical research agency has traditionally enjoyed.
